Melatonin-induced autophagy is associated with degradation of MyoD protein in C2C12 myoblast cells

Journal of Pineal Research

Volumn 53, Issue 3, 2012, Pages 289-297

  Kim, Chi Hyun ^a   Kim, Kyung Hwan ^a   Yoo, Yeong Min ^a  

^a Yonsei University Wonju   (South Korea)

Author keywords

autophagy; C2C12 cells; lysosomal degradation; melatonin; MyoD

Indexed keywords

BECLIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MELATONIN; MYOD PROTEIN; PROTEASOME; PROTEIN KINASE B; RAS PROTEIN; UBIQUITIN;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CYTOSOL; DOSE RESPONSE; LYSOSOME; MOUSE; MYOBLAST; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

ANIMALS; AUTOPHAGY; BCL-2-ASSOCIATED X PROTEIN; CELL LINE; LYSOSOMES; MELATONIN; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MYOBLASTS; MYOD PROTEIN;

EID: 84866247938     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2012.00998.x     Document Type: Article

References (74)

1. Yorimitsu T, Klionsky DJ,. Autophagy: molecular machinery for self-eating. Cell Death Differ 2005; 12: 1542-1552. (Pubitemid 41553991)
2. Lum JJ, Bauer DE, Kong M, et al., Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120: 237-248. (Pubitemid 40174766)
3. Yang Z, Klionsky DJ,. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12: 814-822.
4. Cuervo AM,. Autophagy: in sickness and in health. Trends Cell Biol 2004; 14: 70-77. (Pubitemid 38186640)
5. Shintani T, Klionsky DJ,. Autophagy in health and disease: a double-edged sword. Science 2004; 306: 990-995. (Pubitemid 39482894)
6. Kondo Y, Kanzawa T, Sawaya R, Kondo S,. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5: 726-734. (Pubitemid 41486365)
7. Levine B, Kroemer G,. Autophagy in aging, disease and death: the true identity of a cell death impostor. Cell Death Differ 2009; 16: 1-2.
8. Pizarro JG, Yeste-Velasco M, Esparza JL, et al., The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes. J Pineal Res 2008; 45: 8-16. (Pubitemid 351986256)
9. Sainz RM, Reiter RJ, Tan DX, et al., Critical role of glutathione in melatonin enhancement of tumor necrosis factor and ionizing radiation-induced apoptosis in prostate cancer cells in vitro. J Pineal Res 2008; 45: 258-270.
10. Rodriguez C, Mayo JC, Sainz RM, et al., Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9. (Pubitemid 38130283)
11. Tan DX, Chen LD, Poeggeler B, et al., Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
12. Bonnefont-Rousselot D, Collin F, Jore D, et al., Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. J Pineal Res 2011; 50: 328-335.
13. Gitto E, Pellegrino S, Gitto P, et al., Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009; 46: 128-139.
14. Han F, Chen YX, Lu YM, et al., Regulation of the ischemia-induced autophagy-lysosome processes by nitrosative stress in endothelial cells. J Pineal Res 2011; 51: 124-135.
15. Jou MJ, Peng TI, Reiter RJ, et al., Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004; 37: 55-70. (Pubitemid 38969021)
16. 2-mediated cell death in rat pituitary GH3 cells. J Pineal Res 2009; 47: 301-307.
17. 2+ -mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res 2010; 48: 20-38.
18. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
19. Paradies G, Petrosillo G, Paradies V, et al., Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310.
20. Kongsuphol P, Mukda S, Nopparat C, et al., Melatonin attenuates methamphetamine-induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK-N-SH cells. J Pineal Res 2009; 46: 199-206.
21. Kim CH, Kim KH, Yoo YM,. Melatonin protects against apoptotic and autophagic cell death in C2C12 murine myoblast cells. J Pineal Res 2011; 50: 241-249.
22. Yoo YM, Jeung EB,. Melatonin suppresses cyclosporine A-induced autophagy in rat pituitary GH3 cells. J Pineal Res 2010; 48: 204-211.
23. Halevy O, Novitch BG, Spicer DB, et al., Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267: 1018-1021.
24. Guo K, Wang J, Andrés V, et al., MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 1995; 15: 3823-3829.
25. Martelli F, Cenciarelli C, Santarelli G, et al., MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene 1994; 9: 3579-3590. (Pubitemid 24359396)
26. Gu W, Schneider JW, Condorelli G, et al., Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 1993; 72: 309-324. (Pubitemid 23059403)
27. Trouche D, Grigoriev M, Lenormand JL, et al., Repression of c-fos promoter by MyoD on muscle cell differentiation. Nature 1993; 363: 79-82. (Pubitemid 23144966)
28. Zhang JM, Zhao X, Wei Q, Paterson BM,. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. EMBO J 1999; 18: 6983-6993. (Pubitemid 30000451)
29. Jagoe RT, Goldberg AL,. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care 2001; 4: 183-190. (Pubitemid 33682075)
30. Bodine SC, Latres E, Baumhueter S, et al., Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294: 1704-1708. (Pubitemid 33104839)
31. Gomes MD, Lecker SH, Jagoe RT, et al., Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 2001; 98: 14440-14445. (Pubitemid 33121410)
32. Lagirand-Cantaloube J, Cornille K, Csibi A, et al., Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS ONE 2009; 4: e4973.
33. Tintignac LA, Lagirand J, Batonnet S, et al., Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J Biol Chem 2005; 280: 2847-2856. (Pubitemid 40189393)
34. Megeney LA, Kablar B, Garrett K, et al., MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 1996; 10: 1173-1183. (Pubitemid 26171100)
35. Hughes SM, Koishi K, Rudnicki MA, Maggs AM,. MyoD protein is differentially accumulated in fast and slow skeletal muscle fibres and required for normal fibre type balance in rodents. Mech Dev 1997; 61: 151-163. (Pubitemid 27115950)
36. Brack AS, Bildsoe H, Hughes SM,. Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy. J Cell Sci 2005; 118: 4813-4821. (Pubitemid 41646389)
37. Ishido M, Kami K, Masuhara M,. Localization of MyoD, myogenin and cell cycle regulatory factors in hypertrophying rat skeletal muscles. Acta Physiol Scand 2004; 180: 281-289. (Pubitemid 38299639)
38. Ishido M, Kami K, Masuhara M,. In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle. Am J Physiol Cell Physiol 2004; 287: 484-493.
39. Abu Hatoum O, Gross-Mesilaty S, Breitschopf K, et al., Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: regulation by specific DNA binding. Mol Cell Biol 1998; 18: 5670-5677. (Pubitemid 28450518)
40. Batonnet-Pichon S, Tintignac LJ, Castro A, et al., MyoD undergoes a distinct G2/M-specific regulation in muscle cells. Exp Cell Res 2006; 312: 3999-4010. (Pubitemid 44834515)
41. Song A, Wang Q, Goebl MG, Harrington MA,. Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol 1998; 18: 4994-4999. (Pubitemid 28388082)
42. Kelly SM, Vanslyke JK, Musil LS,. Regulation of ubiquitin-proteasome system mediated degradation by cytosolic stress. Mol Biol Cell 2007; 18: 4279-4291. (Pubitemid 350060158)
43. Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL,. Determinants of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD. J Biol Chem 2003; 278: 1817-1823. (Pubitemid 36801418)
44. Floyd ZE, Trausch-Azar JS, Reinstein E, et al., The nuclear ubiquitin-proteasome system degrades MyoD. J Biol Chem 2001; 276: 22468-22475.
45. Batonnet S, Leibovitch MP, Tintignac L, Leibovitch SA,. Critical role for lysine 133 in the nuclear ubiquitin-mediated degradation of MyoD. J Biol Chem 2004; 279: 5413-5420. (Pubitemid 38220564)
46. Sadeh R, Breitschopf K, Bercovich B, et al., The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system. Proc Natl Acad Sci U S A 2008; 105: 15690-15695.
47. Kabeya Y, Mizushima N, Ueno T, et al., LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19: 5720-5728.
48. Combaret L, Dardevet D, Rieu I, et al., A leucine-supplemented diet restores the defective postprandial inhibition of proteasome-dependent proteolysis in aged rat skeletal muscle. J Physiol 2005; 569: 489-499. (Pubitemid 41830117)
49. Wohlgemuth SE, Seo AY, Marzetti E, et al., Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp Gerontol 2010; 45: 138-148.
50. Lowell BB, Ruderman NB, Goodman MN,. Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem J 1986; 234: 237-240. (Pubitemid 16053683)
51. Wing SS, Haas AL, Goldberg AL,. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochem J 1995; 307: 639-645.
52. Pandey UB, Nie Z, Batlevi Y, et al., HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007; 447: 859-863. (Pubitemid 46920134)
53. Lemasters JJ,. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 2005; 8: 3-5.
54. Jeong SY, Seol DW,. The role of mitochondria in apoptosis. BMB Rep 2008; 41: 11-22.
55. Marzetti E, Hwang JC, Lees HA, et al., Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. Biochim Biophys Acta 2010; 1800: 235-244.
56. Marzetti E, Wohlgemuth SE, Lees HA, et al., Age-related activation of mitochondrial caspase-independent apoptotic signaling in rat gastrocnemius muscle. Mech Ageing Dev 2008; 129: 542-549.
57. Ciechanover A,. The ubiquitin-proteasome proteolytic pathway. Cell 1994; 79: 13-21. (Pubitemid 24309509)
58. Coux O, Tanaka K, Goldberg AL,. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996; 65: 801-847. (Pubitemid 26255262)
59. Deshaies RJ,. Make it or break it: the role of ubiquitin-dependent proteolysis in cellular regulation. Trends Cell Biol 1995; 5: 428-434.
60. Hochstrasser M,. Ubiquitin-dependent protein degradation. Annu Rev Genet 1996; 30: 405-439. (Pubitemid 27014474)
61. McPherron AC, Lawler AM, Lee SJ,. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90. (Pubitemid 27202654)
62. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, et al., Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A 1998; 95: 14938-14943. (Pubitemid 29003735)
63. Zachwieja J, Smith S, Sinha-Hikim I, et al., Myostatin-immunoreactive protein is increased after prolonged bed rest with low-dose T3 administration. J Gravit Physiol 1999; 6: 11-16.
64. Wehling M, Cai B, Tidball JG,. Modulation of myostatin expression during modified muscle use. FASEB J 2000; 14: 103-110. (Pubitemid 30051528)
65. Matsakas A, Foster K, Otto A, et al., Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice. Neuromuscul Disord 2009; 19: 489-499.
66. Martin CI, Johnston IA,. The role of myostatin and the calcineurin-signalling pathway in regulating muscle mass in response to exercise training in the rainbow trout Oncorhynchus mykiss Walbaum. J Exp Biol 2005; 208: 2083-2090. (Pubitemid 40849978)
67. Sakuma K, Watanabe K, Sano M, et al., Differential adaptation of growth and differentiation factor 8/myostatin, fibroblast growth factor 6, and leukemia inhibitory factor in overloaded, regenerating and denervated rat muscles. Biochim Biophys Acta 2000; 1497: 77-88. (Pubitemid 30330892)
68. Rios R, Carneiro I, Arce VM, Devesa J,. Myostatin regulates cell survival during C2C12 myogenesis. Biochem Biophys Res Commun 2001; 280: 561-566. (Pubitemid 32912828)
69. Taylor WE, Bhasin S, Artaza J, et al., Myostatin inhibits cell proliferation and protein synthesis in C(2)C(12) muscle cells. Am J Physiol Endocrinol Metab 2001; 280: E221-E228.
70. Bass J, Oldham J, Sharma M, Kambadur R,. Growth factors controlling muscle development. Domest Anim Endocrinol 1999; 17: 191-197. (Pubitemid 29480331)
71. Artaza JN, Bhasin S, Mallidis C, et al., Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells. J Cell Physiol 2002; 190: 170-179. (Pubitemid 34030568)
72. Lecker SH, Solomon V, Mitch WE, Goldberg AL,. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 1999; 129: 227S-237S. (Pubitemid 29035981)
73. Mammucari C, Milan G, Romanello V, et al., FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007; 6: 458-471. (Pubitemid 350163055)
74. Zhao J, Brault JJ, Schild A, et al., FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007; 6: 472-483. (Pubitemid 350163056)